Cargando…

Polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model

PURPOSE: Sonodynamic therapy is a developing noninvasive modality for cancer treatment, based on the selective activation of a sonosensitizer agent by acoustic cavitation. The activated sonosensitizer agent might generate reactive oxygen species leading to cancer cell death. We investigated the pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Canaparo, Roberto, Varchi, Greta, Ballestri, Marco, Foglietta, Federica, Sotgiu, Giovanna, Guerrini, Andrea, Francovich, Andrea, Civera, Pierluigi, Frairia, Roberto, Serpe, Loredana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826853/
https://www.ncbi.nlm.nih.gov/pubmed/24232189
http://dx.doi.org/10.2147/IJN.S51070
_version_ 1782290969251545088
author Canaparo, Roberto
Varchi, Greta
Ballestri, Marco
Foglietta, Federica
Sotgiu, Giovanna
Guerrini, Andrea
Francovich, Andrea
Civera, Pierluigi
Frairia, Roberto
Serpe, Loredana
author_facet Canaparo, Roberto
Varchi, Greta
Ballestri, Marco
Foglietta, Federica
Sotgiu, Giovanna
Guerrini, Andrea
Francovich, Andrea
Civera, Pierluigi
Frairia, Roberto
Serpe, Loredana
author_sort Canaparo, Roberto
collection PubMed
description PURPOSE: Sonodynamic therapy is a developing noninvasive modality for cancer treatment, based on the selective activation of a sonosensitizer agent by acoustic cavitation. The activated sonosensitizer agent might generate reactive oxygen species leading to cancer cell death. We investigated the potential poly-methyl methacrylate core-shell nanoparticles (NPs) loaded with meso-tetrakis (4-sulfonatophenyl) porphyrin (TPPS) have to function as an innovative sonosensitizing system, ie, TPPS-NPs. METHODS: Shockwaves (SWs) generated by a piezoelectric device were used to induce acoustic cavitation. The cytotoxic effect of the sonodynamic treatment with TPPS-NPs and SWs was investigated on the human neuroblastoma cell line, SH-SY5Y. Cells were exposed for 12 hours to TPPS-NPs (100 μg/mL) and then to SWs (0.43 mJ/mm(2) for 500 impulses, 4 impulses/second). Treatment with SWs, TPPS, and NPs alone or in combination was carried out as control. RESULTS: There was a statistically significant decrease in SH-SY5Y cell proliferation after the sonodynamic treatment with TPPS-NPs and SWs. Indeed, there was a significant increase in necrotic (16.91% ± 3.89%) and apoptotic (27.45% ± 3.03%) cells at 48 hours. Moreover, a 15-fold increase in reactive oxygen species production for cells exposed to TPPS-NPs and SWs was observed at 1 hour compared with untreated cells. A statistically significant enhanced mRNA (messenger ribonucleic acid) expression of NRF2 (P<0.001) and a significant downregulation of TIGAR (P<0.05) and MAP3K5 (P<0.05) genes was observed in cells exposed to TPPS-NPs and SWs at 24 hours, along with a statistically significant release of cytochrome c (P<0.01) at 48 hours. Lastly, the sonosensitizing system was also investigated in an in vitro three-dimensional model, and the sonodynamic treatment significantly decreased the neuroblastoma spheroid growth. CONCLUSION: The sonosensitizing properties of TPPS were significantly enhanced once loaded onto NPs, thus enhancing the sonodynamic treatment’s efficacy in an in vitro neuroblastoma model.
format Online
Article
Text
id pubmed-3826853
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-38268532013-11-14 Polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model Canaparo, Roberto Varchi, Greta Ballestri, Marco Foglietta, Federica Sotgiu, Giovanna Guerrini, Andrea Francovich, Andrea Civera, Pierluigi Frairia, Roberto Serpe, Loredana Int J Nanomedicine Original Research PURPOSE: Sonodynamic therapy is a developing noninvasive modality for cancer treatment, based on the selective activation of a sonosensitizer agent by acoustic cavitation. The activated sonosensitizer agent might generate reactive oxygen species leading to cancer cell death. We investigated the potential poly-methyl methacrylate core-shell nanoparticles (NPs) loaded with meso-tetrakis (4-sulfonatophenyl) porphyrin (TPPS) have to function as an innovative sonosensitizing system, ie, TPPS-NPs. METHODS: Shockwaves (SWs) generated by a piezoelectric device were used to induce acoustic cavitation. The cytotoxic effect of the sonodynamic treatment with TPPS-NPs and SWs was investigated on the human neuroblastoma cell line, SH-SY5Y. Cells were exposed for 12 hours to TPPS-NPs (100 μg/mL) and then to SWs (0.43 mJ/mm(2) for 500 impulses, 4 impulses/second). Treatment with SWs, TPPS, and NPs alone or in combination was carried out as control. RESULTS: There was a statistically significant decrease in SH-SY5Y cell proliferation after the sonodynamic treatment with TPPS-NPs and SWs. Indeed, there was a significant increase in necrotic (16.91% ± 3.89%) and apoptotic (27.45% ± 3.03%) cells at 48 hours. Moreover, a 15-fold increase in reactive oxygen species production for cells exposed to TPPS-NPs and SWs was observed at 1 hour compared with untreated cells. A statistically significant enhanced mRNA (messenger ribonucleic acid) expression of NRF2 (P<0.001) and a significant downregulation of TIGAR (P<0.05) and MAP3K5 (P<0.05) genes was observed in cells exposed to TPPS-NPs and SWs at 24 hours, along with a statistically significant release of cytochrome c (P<0.01) at 48 hours. Lastly, the sonosensitizing system was also investigated in an in vitro three-dimensional model, and the sonodynamic treatment significantly decreased the neuroblastoma spheroid growth. CONCLUSION: The sonosensitizing properties of TPPS were significantly enhanced once loaded onto NPs, thus enhancing the sonodynamic treatment’s efficacy in an in vitro neuroblastoma model. Dove Medical Press 2013 2013-11-06 /pmc/articles/PMC3826853/ /pubmed/24232189 http://dx.doi.org/10.2147/IJN.S51070 Text en © 2013 Canaparo et al. This work is published by Dove Medical Press Ltd, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Ltd, provided the work is properly attributed.
spellingShingle Original Research
Canaparo, Roberto
Varchi, Greta
Ballestri, Marco
Foglietta, Federica
Sotgiu, Giovanna
Guerrini, Andrea
Francovich, Andrea
Civera, Pierluigi
Frairia, Roberto
Serpe, Loredana
Polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model
title Polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model
title_full Polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model
title_fullStr Polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model
title_full_unstemmed Polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model
title_short Polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model
title_sort polymeric nanoparticles enhance the sonodynamic activity of meso-tetrakis (4-sulfonatophenyl) porphyrin in an in vitro neuroblastoma model
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3826853/
https://www.ncbi.nlm.nih.gov/pubmed/24232189
http://dx.doi.org/10.2147/IJN.S51070
work_keys_str_mv AT canaparoroberto polymericnanoparticlesenhancethesonodynamicactivityofmesotetrakis4sulfonatophenylporphyrininaninvitroneuroblastomamodel
AT varchigreta polymericnanoparticlesenhancethesonodynamicactivityofmesotetrakis4sulfonatophenylporphyrininaninvitroneuroblastomamodel
AT ballestrimarco polymericnanoparticlesenhancethesonodynamicactivityofmesotetrakis4sulfonatophenylporphyrininaninvitroneuroblastomamodel
AT fogliettafederica polymericnanoparticlesenhancethesonodynamicactivityofmesotetrakis4sulfonatophenylporphyrininaninvitroneuroblastomamodel
AT sotgiugiovanna polymericnanoparticlesenhancethesonodynamicactivityofmesotetrakis4sulfonatophenylporphyrininaninvitroneuroblastomamodel
AT guerriniandrea polymericnanoparticlesenhancethesonodynamicactivityofmesotetrakis4sulfonatophenylporphyrininaninvitroneuroblastomamodel
AT francovichandrea polymericnanoparticlesenhancethesonodynamicactivityofmesotetrakis4sulfonatophenylporphyrininaninvitroneuroblastomamodel
AT civerapierluigi polymericnanoparticlesenhancethesonodynamicactivityofmesotetrakis4sulfonatophenylporphyrininaninvitroneuroblastomamodel
AT frairiaroberto polymericnanoparticlesenhancethesonodynamicactivityofmesotetrakis4sulfonatophenylporphyrininaninvitroneuroblastomamodel
AT serpeloredana polymericnanoparticlesenhancethesonodynamicactivityofmesotetrakis4sulfonatophenylporphyrininaninvitroneuroblastomamodel